Search

everythinglearnresearchcommunity

for

Search:↓

Loose anagen hair syndrome is caused by structural abnormalities in the hair follicle's inner root sheath.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

An 11-month-old boy with Menkes disease had severe brain shrinkage and abnormal blood vessels, and didn't respond well to treatment.

A 78-year-old man with Cronkhite-Canada syndrome improved significantly after treatment and remains symptom-free.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

A Laotian man with unusual skin changes and multiple growths in his gut was diagnosed with Cronkhite-Canada Syndrome and improved with nutritional and immune-based treatments.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Lower SHBG levels may increase the risk of PCOS.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

PCOS is a common condition in women that causes various symptoms and health issues, treatable with lifestyle changes and medication.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.